Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-24 @ 5:03 PM
NCT ID:
NCT05590650
Eligibility Criteria:
Inclusion Criteria:
* aged from 20- to 65-year-old;
* firstly diagnosed as head and neck cancer with stage II, III or IV;
* adjuvant therapy with chemotherapy of Cisplatin or combined with radiotherapy after surgery;
* or chemotherapy of Cisplatin for those without surgery;
* wiliness to sign inform consent.
Exclusion Criteria:
* pregnancy;
* non-Squamous-cell carcinoma;
* secondary cancer or Carcinoma in situ in 5 years;
* any evidence of metastasis;
* abnormality of liver, kidney or bone marrow functions before treatments;
* unstable vital signs;
* episode of acute infection;
* unclear consciousness for inform consent;
* receiving other herbal, complementary or acupuncture therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
65 Years
Study:
NCT05590650
Study Brief:
Protocol Section:
NCT05590650